Skip to main content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
J Clin Invest. 1989 Oct; 84(4): 1114–1123.
PMCID: PMC329767
PMID: 2551923

Immune response to B19 parvovirus and an antibody defect in persistent viral infection.

Abstract

B19 parvovirus has been shown to persist in some immunocompromised patients, and treatment with specific antibodies can lead to decreased quantities of circulating virus and hematologic improvement. A defective immune response to B19 parvovirus in these patients was shown by comparison of results using a capture RIA and immunoblotting. In normal individuals, examination of paired sera showed that the dominant humoral immune response during early convalescence was to the virus major capsid protein (58 kD) and during late convalescence to the minor capsid species (83 kD). In patients with persistent parvovirus infection, variable titers against intact particles were detected by RIA, but the sera from these patients had minimal or no IgG to capsid proteins determined by Western analysis. Competition experiments suggested that this discrepancy was not explicable on the basis of immune complex formation alone and that these patients may have a qualitative abnormality in antibody binding to virus. In neutralization experiments, in which erythroid colony formation in vitro was used as an assay of parvovirus activity, sera from patients with poor reactivity on immunoblotting were also inadequate in inhibiting viral infectivity. A cellular response to purified B19 parvovirus could not be demonstrated using proliferation assays and PBMC from individuals with serologic evidence of exposure to virus. These results suggest that production of neutralizing antibody to capsid protein plays a major role in limiting parvovirus infection in man.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (2.8M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  • Young N. Hematologic and hematopoietic consequences of B19 parvovirus infection. Semin Hematol. 1988 Apr;25(2):159–172. [PubMed] [Google Scholar]
  • Mortimer PP, Humphries RK, Moore JG, Purcell RH, Young NS. A human parvovirus-like virus inhibits haematopoietic colony formation in vitro. Nature. 302(5907):426–429. [PubMed] [Google Scholar]
  • Young NS, Mortimer PP, Moore JG, Humphries RK. Characterization of a virus that causes transient aplastic crisis. J Clin Invest. 1984 Jan;73(1):224–230. [PMC free article] [PubMed] [Google Scholar]
  • Anderson MJ, Higgins PG, Davis LR, Willman JS, Jones SE, Kidd IM, Pattison JR, Tyrrell DA. Experimental parvoviral infection in humans. J Infect Dis. 1985 Aug;152(2):257–265. [PubMed] [Google Scholar]
  • Kurtzman GJ, Ozawa K, Cohen B, Hanson G, Oseas R, Young NS. Chronic bone marrow failure due to persistent B19 parvovirus infection. N Engl J Med. 1987 Jul 30;317(5):287–294. [PubMed] [Google Scholar]
  • Kurtzman GJ, Cohen B, Meyers P, Amunullah A, Young NS. Persistent B19 parvovirus infection as a cause of severe chronic anaemia in children with acute lymphocytic leukaemia. Lancet. 1988 Nov 19;2(8621):1159–1162. [PubMed] [Google Scholar]
  • Clewley JP. Detection of human parvovirus using a molecularly cloned probe. J Med Virol. 1985 Feb;15(2):173–181. [PubMed] [Google Scholar]
  • Kurtzman GJ, Gascon P, Caras M, Cohen B, Young NS. B19 parvovirus replicates in circulating cells of acutely infected patients. Blood. 1988 May;71(5):1448–1454. [PubMed] [Google Scholar]
  • Ozawa K, Kurtzman G, Young N. Replication of the B19 parvovirus in human bone marrow cell cultures. Science. 1986 Aug 22;233(4766):883–886. [PubMed] [Google Scholar]
  • Cohen BJ, Mortimer PP, Pereira MS. Diagnostic assays with monoclonal antibodies for the human serum parvovirus-like virus (SPLV). J Hyg (Lond) 1983 Aug;91(1):113–130. [PMC free article] [PubMed] [Google Scholar]
  • Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. [PubMed] [Google Scholar]
  • Ozawa K, Young N. Characterization of capsid and noncapsid proteins of B19 parvovirus propagated in human erythroid bone marrow cell cultures. J Virol. 1987 Aug;61(8):2627–2630. [PMC free article] [PubMed] [Google Scholar]
  • Ozawa K, Ayub J, Young N. Functional mapping of the genome of the B19 (human) parvovirus by in vitro translation after negative hybrid selection. J Virol. 1988 Jul;62(7):2508–2511. [PMC free article] [PubMed] [Google Scholar]
  • Cotmore SF, McKie VC, Anderson LJ, Astell CR, Tattersall P. Identification of the major structural and nonstructural proteins encoded by human parvovirus B19 and mapping of their genes by procaryotic expression of isolated genomic fragments. J Virol. 1986 Nov;60(2):548–557. [PMC free article] [PubMed] [Google Scholar]
  • Saarinen UM, Chorba TL, Tattersall P, Young NS, Anderson LJ, Palmer E, Coccia PF. Human parvovirus B19-induced epidemic acute red cell aplasia in patients with hereditary hemolytic anemia. Blood. 1986 May;67(5):1411–1417. [PubMed] [Google Scholar]
  • Chorba T, Coccia P, Holman RC, Tattersall P, Anderson LJ, Sudman J, Young NS, Kurczynski E, Saarinen UM, Moir R, et al. The role of parvovirus B19 in aplastic crisis and erythema infectiosum (fifth disease). J Infect Dis. 1986 Sep;154(3):383–393. [PubMed] [Google Scholar]
  • Schwarz TF, Roggendorf M, Deinhardt F. Human parvovirus B19: ELISA and immunoblot assays. J Virol Methods. 1988 Jun;20(2):155–168. [PubMed] [Google Scholar]
  • Surleraux M, Bodeus M, Burtonboy G. Study of canine parvovirus polypeptides by immunoblot analysis. Arch Virol. 1987;95(3-4):271–281. [PubMed] [Google Scholar]
  • Shade RO, Blundell MC, Cotmore SF, Tattersall P, Astell CR. Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis. J Virol. 1986 Jun;58(3):921–936. [PMC free article] [PubMed] [Google Scholar]
  • An SH, Wilkie BN. Mitogen- and viral antigen-induced transformation of lymphocytes from normal mink and from mink with progressive or nonprogressive Aleutian disease. Infect Immun. 1981 Oct;34(1):111–114. [PMC free article] [PubMed] [Google Scholar]
  • Race RE, Bloom ME, Coe JE. Demonstration of Aleutian disease virus-specific lymphocyte response in mink with progressive Aleutian disease: comparison of sapphire and pastel mink infected with different virus strains. J Immunol. 1983 Sep;131(3):1558–1564. [PubMed] [Google Scholar]
  • Alexandersen S, Bloom ME, Wolfinbarger J. Evidence of restricted viral replication in adult mink infected with Aleutian disease of mink parvovirus. J Virol. 1988 May;62(5):1495–1507. [PMC free article] [PubMed] [Google Scholar]
  • Anand A, Gray ES, Brown T, Clewley JP, Cohen BJ. Human parvovirus infection in pregnancy and hydrops fetalis. N Engl J Med. 1987 Jan 22;316(4):183–186. [PubMed] [Google Scholar]
  • Schultz RD, Mendel H, Scott FW. Effect of feline panleukopenia virus infection on development of humoral and cellular immunity. Cornell Vet. 1976 Jul;66(3):324–332. [PubMed] [Google Scholar]
  • Paul PS, Mengeling WL, Brown TT., Jr Replication of porcine parvovirus in peripheral blood lymphocytes, monocytes, and peritoneal macrophages. Infect Immun. 1979 Sep;25(3):1003–1007. [PMC free article] [PubMed] [Google Scholar]
  • Engers HD, Louis JA, Zubler RH, Hirt B. Inhibition of T cell-mediated functions by MVM(i), a parvovirus closely related to minute virus of mice. J Immunol. 1981 Dec;127(6):2280–2285. [PubMed] [Google Scholar]
  • An SH, Ingram DG. Detection of inapparent Aleutian disease virus infection in mink. Am J Vet Res. 1977 Oct;38(10):1619–1624. [PubMed] [Google Scholar]
  • Csiza CK, Scott FW, de Lahunta A, Gillespie JH. Immune carrier state of feline panleukopenia virus-infected cats. Am J Vet Res. 1971 Mar;32(3):419–426. [PubMed] [Google Scholar]
  • Johnson RH, Collings DF. Transplacental infection of piglets with a porcine parvovirus. Res Vet Sci. 1971 Nov;12(6):570–572. [PubMed] [Google Scholar]
  • Porter DD. Aleutian disease: a persistent parvovirus infection of mink with a maximal but ineffective host humoral immune response. Prog Med Virol. 1986;33:42–60. [PubMed] [Google Scholar]
  • Steiner LA, Eisen HN. Sequential changes in the relative affinity of antibodies synthesized during the immune response. J Exp Med. 1967 Dec 1;126(6):1161–1183. [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation